Delhi: IHH Healthcare, a prominent global healthcare provider, has escalated its legal battle with Japan's Daiichi Sankyo, ...

IHH-LITIGATION-DAIICHI-SANKYO:IHH Healthcare’s damages against Daiichi could reach $1.25 billion, expert report says (Feb 6) ...

If the trial is successful, the firm's complete estrogen receptor antagonist would complement its other biomarker-driven breast cancer assets.

The Quarterly Results page of Dai Ichi Karkaria Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.